Bett from Bio E contains Vaccine, Tetanus Toxoid, Tetanus Toxoid Adsorbed. Tetanus vaccine is a vaccine used against Clostridium tetani, the agent that causes tetanus. It is a component of the DPT vaccine. The tetanus vaccine is required yearly if the individual is exposed to possible infection. During childhood, five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended.
Bett is product from Biological E. Established during the ‘Swadeshi Movement’ of India, Biological E. Limited (BE) started during a time when the nation sought access to critical healthcare products. Founded and led by Dr. DVK Raju, Biological E. Limited commenced its operations in 1953 as a biological products company manufacturing liver extracts and anti-coagulants.
With an objective of transitioning from treating diseases to preventing them, Biological E. Limited launched its Biotechnology Division (now Vaccines and Biologics Division) and commenced large-scale production of DPT vaccines as early as 1962. Biological E. Limited continues to evolve as an organisation and currently has four strategic business units: Branded Formulations, Speciality Generic Injectables, Synthetic Biology and Vaccines and Biologics.
Tetanus is a serious disease caused by a bacterial toxin that affects your nervous system, leading to painful muscle contractions, particularly of your jaw and neck muscles. Tetanus can interfere with your ability to breathe and can threaten your life. Tetanus is commonly known as “lockjaw.”
Thanks to the tetanus vaccine, cases of tetanus are rare in the United States and other parts of the developed world. But the disease remains a threat to those who aren’t up to date on their vaccinations. It’s more common in developing countries. There’s no cure for tetanus. Treatment focuses on managing complications until the effects of the tetanus toxin resolve.
As directed by your Physician
As directed by your Physician
Adverse Reactions/ Side Effects
Mild injection site reactions eg transient swelling, rash, fever, malaise, tiredness, nausea, vomiting, arthralgias, pruritus and dizziness.
Potentially Fatal: Anaphylactic reactions.
Warnings and Precautions
Epinepherine injection (1:1000) and other appropriate agents and equipment must be immediately available should an acute anaphylactic reaction occur.
Prior to the administration of MassBiologics’ Td, the vaccine recipient’s current health status and health history should be reviewed. This includes a review of the immunization history of the patient, the presence of any contraindications to immunization, and any adverse events after previous immunizations to allow an assessment of the benefits and risks of vaccination.
If MassBiologics’ Td is administered to immunocompromised persons (whether from disease or treatment) the expected immune response may not be obtained.
Do not administer IV. Use subcutaneous route in bleeding disorders. Withhold vaccination in moderate or severe febrile illness. Pregnancy, lactation, history of Guillian-Barre syndrome.
Caution when used during pregnancy. Caution when used during lactation.
In Children- MassBiologics’ Td is not approved for use in infants and children younger than 7 years of age. The safety and effectiveness of MassBiologics’ Td in this age group have not been established.
Decreased immunologic response with concurrent immunosuppressants. Neutralisation of tetanus immune globulin and tetanus toxoid adsorbed if not given at different sites using different syringes.
Mechanism of Action
Tetanus toxoid and tetanus toxoid adsorbed induces active immunity to the tetanus antigen by stimulating the immune system to produce specific antitoxin. They are not indicated for the treatment of active tetanus infection.